Medication and Treatment for Disease
AssigneeAitman Enterprises LLC
InventorMitchell S. Felder
Life of this patent
Estimating the term…
Abstract
A treatment is described for diseases with symptoms that can include fatigue, muscle aches and spasms, weakness, demylenation, and nerve pain. Diseases can include fibromyalgia, depression, and auto-immune and immuno-suppressive diseases, such as MS. The treatment comprises about 1-10 mg naltrexone, at least about 20 μg vitamin B12, at least about 5 mg vitamin B6, at least about 2 mg coenzyme Q, and preferably at least one ancillary medication selected from the group consisting of diazepam, cyclcobenzaprine, clonazepam, alprazolam, 9-tetrahydrocannibinol, fumarate, caffeine, and combinations thereof. The treatment can be administered orally, and can decrease mental and physical symptoms such as, for example, fatigue, gait problems, visual dysfunction, and pain while improving cognitive skills.
Claims21
1-18. (canceled)
A medication for disease comprising low dose naltrexone, coenzyme Q, and vitamins B12 and B6.
A treatment for disease comprising a medication comprising a low dose naltrexone, coenzyme Q, and vitamins B12 and B6.
A medication for disease comprising 1 mg to about 10 mg naltrexone, at least about 2 mg coenzyme Q, and at least about 20 μg vitamin B12, and at least about 5 mg vitamin B6.
Dependencies are inferred from the claim text.